The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
No Access

Implications of increased dosage of neuroleptic medications during psychotherapy

Published Online:https://doi.org/10.1176/ajp.136.6.824

Unrecognized emotional reactions on the part of the psychiatric trainee may result in the inappropriate use of medications. To illustrate the possibility that increases in medication dosages may be related to the psychiatric clinician's lack of control, the authors present three clinical examples and discuss the concept of countertransference. A model of supervision is described in which the supervisor, trainee, and patient meet to correct these therapeutic distortions and reduce the amount of medication required.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.